12 results on '"Duse, Adriano"'
Search Results
2. Tuberculosis control at a South African correctional centre: Diagnosis, treatment and strain characterisation.
- Author
-
Baird, Kathleen, Said, Halima, Koornhof, Hendrik J., and Duse, Adriano Gianmaria
- Subjects
MYCOBACTERIUM tuberculosis ,TUBERCULOSIS ,DIAGNOSIS ,PRISONS ,INFECTIOUS disease transmission ,CORRECTIONS (Criminal justice administration) ,CORRECTIONAL institutions - Abstract
Background: Correctional centres provide ideal conditions for tuberculosis (TB) transmission and disease progression. Despite the high TB incidence and incarceration rate in South Africa, data from South African correctional centres are scarce. Thus, the study evaluated TB diagnosis, treatment initiation and completion, and identified prevalent Mycobacterium tuberculosis strains among detainees entering a South African correctional centre. Methods: This study was a prospective observational study that enrolled participants between February and September 2017 from a correctional centre located in the Western Cape, South Africa. All adult male detainees who tested positive for TB during admission screening were eligible to participate in the study. Sputum samples from enrolled participants underwent smear microscopy and culture. Strain typing was performed on culture-positive samples. The time between specimen collection and diagnosis, the time between diagnosis and treatment initiation, and the proportion of detainees completing TB treatment at the correctional centre were calculated. Results: During the study period, 130 TB cases were detected through routine admission screening (126 male, 2 female, 2 juvenile). Out of the 126 eligible male detainees, 102 were enrolled in the study (81%, 102/126). All TB cases were detected within 30 hrs of admission screening. The majority (78%, 80/102) of participants started treatment within 48 hrs of TB diagnosis. However, only 8% (9/102) of participants completed treatment at the correction centre. Sputa from 90 of the 102 participants were available for smear and culture. There was a high smear positivity, with 49% (44/90) of isolates being smear positive. The Beijing family was the most frequent lineage (55.2%) in the study. Conclusion: The strengths of the current TB control efforts at the correctional centre include rapid detection of cases through admission screening and prompt treatment initiation. However, a high number of detainees exiting before treatment completion highlights the need to strengthen links between correctional TB services and community TB services to ensure detainees complete TB treatment after release and prevent TB transmission. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Planning for large epidemics and pandemics: challenges from a policy perspective.
- Author
-
Jain, Vageesh, Duse, Adriano, and Bausch, Daniel G.
- Published
- 2018
- Full Text
- View/download PDF
4. Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against Candida albicans.
- Author
-
Ahmad, Aijaz, Wani, Mohmmad Younus, Patel, Mrudula, Sobral, Abilio J. F. N., Duse, Adriano G., Aqlan, Faisal Mohammed, and Al-Bogami, Abdullah Saad
- Published
- 2017
- Full Text
- View/download PDF
5. Prevalence and Trends of Staphylococcus aureus Bacteraemia in Hospitalized Patients in South Africa, 2010 to 2012: Laboratory-Based Surveillance Mapping of Antimicrobial Resistance and Molecular Epidemiology.
- Author
-
Perovic, Olga, Iyaloo, Samantha, Kularatne, Ranmini, Lowman, Warren, Bosman, Noma, Wadula, Jeannette, Seetharam, Sharona, Duse, Adriano, Mbelle, Nontombi, Bamford, Colleen, Dawood, Halima, Mahabeer, Yesholata, Bhola, Prathna, Abrahams, Shareef, and Singh-Moodley, Ashika
- Subjects
STAPHYLOCOCCUS aureus ,BACTEREMIA prevention ,SOUTH Africans ,ANTI-infective agents ,DRUG resistance ,MOLECULAR epidemiology ,DISEASES - Abstract
Introduction: We aimed to obtain an in-depth understanding on recent antimicrobial resistance trends and molecular epidemiology trends of S. aureus bacteraemia (SAB). Methods: Thirteen academic centres in South Africa were included from June 2010 until July 2012. S. aureus susceptibility testing was performed on the MicroScan Walkaway. Real-time PCR using the LightCycler 480 II was done for mecA and nuc. SCCmec and spa-typing were finalized with conventional PCR. We selected one isolate per common spa type per province for multilocus sequence typing (MLST). Results: S. aureus from 2709 patients were included, and 1231 (46%) were resistant to methicillin, with a significant decline over the three-year period (p-value = 0.003). Geographical distribution of MRSA was significantly higher in Gauteng compared to the other provinces (P<0.001). Children <5 years were significantly associated with MRSA with higher rates compared to all other age groups (P = 0.01). The most prevalent SCCmec type was SCCmec type III (531 [41%]) followed by type IV (402 [31%]). Spa-typing discovered 47 different spa-types. The five (87%) most common spa-types were t037, t1257, t045, t064 and t012. Based on MLST, the commonest was ST612 clonal complex (CC8) (n = 7) followed by ST5 (CC5) (n = 4), ST36 (CC30) (n = 4) and ST239 (CC8) (n = 3). Conclusions: MRSA rate is high in South Africa. Majority of the isolates were classified as SCCmec type III (41%) and type IV (31%), which are typically associated with hospital and community- acquired infections, respectively. Overall, this study reveals the presence of a variety of hospital-acquired MRSA clones in South Africa dominance of few clones, spa 037 and 1257. Monitoring trends in resistance and molecular typing is recommended to detect changing epidemiological trends in AMR patterns of SAB. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
6. Consensus statement: patient safety, healthcare-associated infections and hospital environmental surfaces.
- Author
-
Roques, Christine, Al Mousa, Haifaa, Duse, Adriano, Gallagher, Rose, Koburger, Torsten, Lingaas, Egil, Petrosillo, Nicola, and Škrlin, Jasenka
- Abstract
Healthcare-associated infections have serious implications for both patients and hospitals. Environmental surface contamination is the key to transmission of nosocomial pathogens. Routine manual cleaning and disinfection eliminates visible soil and reduces environmental bioburden and risk of transmission, but may not address some surface contamination. Automated area decontamination technologies achieve more consistent and pervasive disinfection than manual methods, but it is challenging to demonstrate their efficacy within a randomized trial of the multiple interventions required to reduce healthcare-associated infection rates. Until data from multicenter observational studies are available, automated area decontamination technologies should be an adjunct to manual cleaning and disinfection within a total, multi-layered system and risk-based approach designed to control environmental pathogens and promote patient safety. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
7. Molecular characterisation of clinical and environmental isolates of Mycobacterium kansasii isolates from South African gold mines.
- Author
-
Kwenda, Geoffrey, Churchyard, Gavin J., Thorrold, Catherine, Heron, Ian, Stevenson, Karen, Duse, Adriano G., and Marais, Elsé
- Subjects
MYCOBACTERIUM ,LUNG diseases ,GOLD miners ,MOLECULAR epidemiology ,MYCOBACTERIA ,POLYMERASE chain reaction ,DISEASES - Abstract
Mycobacterium kansasii (M. kansasii) is a major cause of non-tuberculous mycobacterial pulmonary disease in the South African gold-mining workforce, but the source of infection and molecular epidemiology are unknown. This study investigated the presence of M. kansasii in gold and coal mine and associated hostel water supplies and compared the genetic diversity of clinical and environmental isolates of M. kansasii. Five M. kansasii and ten other potentially pathogenic mycobacteria were cultured mainly from showerhead biofilms. Polymerase chain reaction-restriction analysis of the hsp65 gene on 196 clinical and environmental M. kansasii isolates revealed 160 subtype I, eight subtype II and six subtype IV strains. Twenty-two isolates did not show the typical M. kansasii restriction patterns, suggesting that these isolates may represent new subtypes of M. kansasii. In contrast to the clonal population structure found amongst the subtype I isolates from studies in other countries, DNA fingerprinting of 114 clinical and three environmental subtype I isolates demonstrated genetic diversity amongst the isolates. This study demonstrated that showerheads are possible sources of M. kansasii and other pathogenic non-tuberculous mycobacterial infection in a gold-mining region, that subtype I is the major clinical isolate of M. kansasii strain and that this subtype exhibits genetic diversity. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
8. Clinical Features and Patient Management of Lujo Hemorrhagic Fever.
- Author
-
Sewlall, Nivesh H., Richards, Guy, Duse, Adriano, Swanepoel, Robert, Paweska, Janusz, Blumberg, Lucille, Dinh, Thu Ha, and Bausch, Daniel
- Subjects
HEMORRHAGIC fever ,MEDICAL personnel ,LASSA fever ,SYMPTOMS ,CHEST pain ,DEVELOPED countries ,GASTROINTESTINAL hemorrhage - Abstract
Background: In 2008 a nosocomial outbreak of five cases of viral hemorrhagic fever due to a novel arenavirus, Lujo virus, occurred in Johannesburg, South Africa. Lujo virus is only the second pathogenic arenavirus, after Lassa virus, to be recognized in Africa and the first in over 40 years. Because of the remote, resource-poor, and often politically unstable regions where Lassa fever and other viral hemorrhagic fevers typically occur, there have been few opportunities to undertake in-depth study of their clinical manifestations, transmission dynamics, pathogenesis, or response to treatment options typically available in industrialized countries. Methods and Findings: We describe the clinical features of five cases of Lujo hemorrhagic fever and summarize their clinical management, as well as providing additional epidemiologic detail regarding the 2008 outbreak. Illness typically began with the abrupt onset of fever, malaise, headache, and myalgias followed successively by sore throat, chest pain, gastrointestinal symptoms, rash, minor hemorrhage, subconjunctival injection, and neck and facial swelling over the first week of illness. No major hemorrhage was noted. Neurological signs were sometimes seen in the late stages. Shock and multi-organ system failure, often with evidence of disseminated intravascular coagulopathy, ensued in the second week, with death in four of the five cases. Distinctive treatment components of the one surviving patient included rapid commencement of the antiviral drug ribavirin and administration of HMG-CoA reductase inhibitors (statins), N-acetylcysteine, and recombinant factor VIIa. Conclusions: Lujo virus causes a clinical syndrome remarkably similar to Lassa fever. Considering the high case-fatality and significant logistical impediments to controlled treatment efficacy trials for viral hemorrhagic fever, it is both logical and ethical to explore the use of the various compounds used in the treatment of the surviving case reported here in future outbreaks. Clinical observations should be systematically recorded to facilitate objective evaluation of treatment efficacy. Due to the risk of secondary transmission, viral hemorrhagic fever precautions should be implemented for all cases of Lujo virus infection, with specialized precautions to protect against aerosols when performing enhanced-risk procedures such as endotracheal intubation. Author Summary: Viral hemorrhagic fever is a syndrome often associated with high fatality and risk of secondary transmission. In 2008, an outbreak of a novel hemorrhagic fever virus called Lujo occurred in Johannesburg, South Africa, with secondary transmission from the index patient to four healthcare workers. Four of the five patients died. Lujo belongs to the arenavirus family and is only the second pathogenic arenavirus, after Lassa virus, to be recognized in Africa and the first in over 40 years. Because most viral hemorrhagic fevers occur in remote, resource-poor settings, few in-depth controlled studies of their clinical manifestations, transmission dynamics, pathogenesis, or response to treatment options are possible. We describe the clinical features of the five cases in this outbreak and summarize the clinical management, as well as providing additional epidemiologic detail. Lujo virus causes a clinical syndrome remarkably similar to Lassa fever. The treatment options used in these five cases are discussed as well as the recommended precautions to prevent secondary transmission. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
9. Clinical Features and Patient Management of Lujo Hemorrhagic Fever.
- Author
-
Sewlall, Nivesh H., Richards, Guy, Duse, Adriano, Swanepoel, Robert, Paweska, Janusz, Blumberg, Lucille, Dinh, Thu Ha, and Bausch, Daniel
- Subjects
HEMORRHAGIC fever ,ARENAVIRUS diseases ,CHIKUNGUNYA ,ALPHAVIRUS diseases ,PSYCHODIAGNOSTICS - Abstract
Background: In 2008 a nosocomial outbreak of five cases of viral hemorrhagic fever due to a novel arenavirus, Lujo virus, occurred in Johannesburg, South Africa. Lujo virus is only the second pathogenic arenavirus, after Lassa virus, to be recognized in Africa and the first in over 40 years. Because of the remote, resource-poor, and often politically unstable regions where Lassa fever and other viral hemorrhagic fevers typically occur, there have been few opportunities to undertake in-depth study of their clinical manifestations, transmission dynamics, pathogenesis, or response to treatment options typically available in industrialized countries. Methods and Findings: We describe the clinical features of five cases of Lujo hemorrhagic fever and summarize their clinical management, as well as providing additional epidemiologic detail regarding the 2008 outbreak. Illness typically began with the abrupt onset of fever, malaise, headache, and myalgias followed successively by sore throat, chest pain, gastrointestinal symptoms, rash, minor hemorrhage, subconjunctival injection, and neck and facial swelling over the first week of illness. No major hemorrhage was noted. Neurological signs were sometimes seen in the late stages. Shock and multi-organ system failure, often with evidence of disseminated intravascular coagulopathy, ensued in the second week, with death in four of the five cases. Distinctive treatment components of the one surviving patient included rapid commencement of the antiviral drug ribavirin and administration of HMG-CoA reductase inhibitors (statins), N-acetylcysteine, and recombinant factor VIIa. Conclusions: Lujo virus causes a clinical syndrome remarkably similar to Lassa fever. Considering the high case-fatality and significant logistical impediments to controlled treatment efficacy trials for viral hemorrhagic fever, it is both logical and ethical to explore the use of the various compounds used in the treatment of the surviving case reported here in future outbreaks. Clinical observations should be systematically recorded to facilitate objective evaluation of treatment efficacy. Due to the risk of secondary transmission, viral hemorrhagic fever precautions should be implemented for all cases of Lujo virus infection, with specialized precautions to protect against aerosols when performing enhanced-risk procedures such as endotracheal intubation. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
10. Nosocomial Outbreak of Novel Arenavirus Infection, Southern Africa.
- Author
-
Paweska, Janusz T., Sewlall, Nivesh H., Ksiazek, Thomas G., Blumberg, Lucille H., Hale, Martin J., Lipkin, W. Ian, Weyer, Jacqueline, Nichol, Stuart T., Rollin, Pierre E., McMullan, Laura K., Paddock, Christopher D., Briese, Thomas, Mnyaluza, Joy, Dinh, Thu-Ha, Mukonka, Victor, Ching, Pamela, Duse, Adriano, Richards, Guy, De Jong, Gillian, and Cohen, Cheryl
- Subjects
ARENAVIRUS diseases ,DISEASE outbreaks ,NOSOCOMIAL infections ,MORTALITY ,VIRUS diseases - Abstract
A nosocomial outbreak of disease involving 5 patients, 4 of whom died, occurred in South Africa during September-October 2008. The first patient had been transferred from Zambia to South Africa for medical management. Three cases involved secondary spread of infection from the first patient, and 1 was a tertiary infection. A novel arenavirus was identified. The source of the first patient's infection remains undetermined. [ABSTRACT FROM AUTHOR]
- Published
- 2009
11. Central Venous Catheterization: A Prospective, Randomized, Double-Blind Study.
- Author
-
Mer, Mervyn, Duse, Adriano Gianmaria, Galpin, Jacqueline Suzanne, and Richards, Guy Antony
- Published
- 2009
- Full Text
- View/download PDF
12. The Global Antibiotic Resistance Partnership (GARP).
- Author
-
Duse, Adriano G.
- Published
- 2011
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.